DK517787A - Lymphokinbeslaegtede peptider - Google Patents
Lymphokinbeslaegtede peptiderInfo
- Publication number
- DK517787A DK517787A DK517787A DK517787A DK517787A DK 517787 A DK517787 A DK 517787A DK 517787 A DK517787 A DK 517787A DK 517787 A DK517787 A DK 517787A DK 517787 A DK517787 A DK 517787A
- Authority
- DK
- Denmark
- Prior art keywords
- lymphocyte
- related peptides
- peptides
- Prior art date
Links
- 210000004698 lymphocyte Anatomy 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
- C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/55—Vector systems having a special element relevant for transcription from bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/70—Vector systems having a special element relevant for transcription from fungi
- C12N2830/702—Vector systems having a special element relevant for transcription from fungi yeast
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB868623850A GB8623850D0 (en) | 1986-10-03 | 1986-10-03 | Lymphokine related peptide |
| GB868628358A GB8628358D0 (en) | 1986-11-27 | 1986-11-27 | Lymphokine related peptides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK517787D0 DK517787D0 (da) | 1987-10-02 |
| DK517787A true DK517787A (da) | 1988-04-04 |
Family
ID=26291377
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK517787A DK517787A (da) | 1986-10-03 | 1987-10-02 | Lymphokinbeslaegtede peptider |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US5350687A (fi) |
| EP (1) | EP0263072B1 (fi) |
| JP (1) | JPH09188698A (fi) |
| AU (1) | AU7930987A (fi) |
| DE (1) | DE3789413T2 (fi) |
| DK (1) | DK517787A (fi) |
| ES (1) | ES2052602T3 (fi) |
| FI (1) | FI874287A (fi) |
| IE (1) | IE61773B1 (fi) |
| NO (1) | NO874159L (fi) |
| PT (1) | PT85849B (fi) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2750604B1 (fr) * | 1996-07-02 | 2002-09-20 | Oreal | Heteromere liant l'acide arachidonique et son utilisation en cosmetique ou pharmacie |
| EP0463037A1 (en) * | 1989-03-17 | 1992-01-02 | Genetics Institute, Inc. | Human macrophage migration inhibitory factor |
| GB8915414D0 (en) * | 1989-07-05 | 1989-08-23 | Ciba Geigy | Novel cytokines |
| JP2747839B2 (ja) * | 1989-08-14 | 1998-05-06 | 花王株式会社 | モノクローナル抗体 |
| US5149544A (en) * | 1989-11-13 | 1992-09-22 | Research Corporation Technologies, Inc. | Method of inhibiting progenitor cell proliferation |
| WO1992004376A1 (en) * | 1990-09-05 | 1992-03-19 | The Heart Research Institute Limited | Novel chemotactic factor |
| CH685959A5 (de) * | 1992-08-24 | 1995-11-15 | Biomedicals Ag | Diagnostische Testpackung zur Bestimmung von Proteinen. |
| US6080407A (en) * | 1993-05-17 | 2000-06-27 | The Picower Institute For Medical Research | Diagnostic assays for MIF |
| US5776348A (en) * | 1995-02-07 | 1998-07-07 | Massachusetts Institute Of Technology | Mineral precipitation system and method for inhibiting mineral precipitate formation |
| AU5923398A (en) | 1997-01-21 | 1998-08-07 | Human Genome Sciences, Inc. | Polynucleotides and polypeptides encoding receptors |
| EP1118681A1 (en) | 1998-09-29 | 2001-07-25 | Asahi Kasei Kabushiki Kaisha | Method for controlling the release of granules |
| IL142971A0 (en) * | 1998-11-05 | 2002-04-21 | Univ Michigan | S100 proteins and autoantibodies as serum markers for cancer |
| UY27304A1 (es) | 2001-05-24 | 2002-12-31 | Avanir Pharmaceuticals | Inhibidores del factor inhibidor de la migración de los macrófagos y métodos para su identificación |
| AU2003212246A1 (en) * | 2002-02-15 | 2003-09-04 | Johannes Roth | Method for diagnosis of inflammatory diseases using mrp8/mrp14 |
| ATE427758T1 (de) | 2002-07-05 | 2009-04-15 | Univ Laval | Inhibitor des chemotaktischen faktors zur hemmung der entzundungsreaktionen |
| TW200418829A (en) | 2003-02-14 | 2004-10-01 | Avanir Pharmaceutics | Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| US7361474B2 (en) * | 2003-02-24 | 2008-04-22 | United States Of America As Represented By The Department Of Veterans Affairs | Serum macrophage migration inhibitory factor (MIF) as marker for prostate cancer |
| WO2004084928A1 (en) | 2003-03-28 | 2004-10-07 | UNIVERSITé LAVAL | S100 protein as neutrophil activator for alleviating neutropenia in cancer treatment |
| EP1656376A1 (en) * | 2003-08-22 | 2006-05-17 | Avanir Pharmaceuticals | Substituted naphthyridine derivatives as inhibitors of macrophage migration inhibitory factor and their use in the treatment of human diseases |
| EP1745194A4 (en) * | 2004-02-25 | 2008-02-06 | Us Dept Veterans Affairs | METHODS FOR DIAGNOSING AND TREATING CANCER OF BLADDER |
| SE0400886D0 (sv) * | 2004-04-02 | 2004-04-02 | Amersham Biosciences Ab | Process of purification |
| WO2006005186A1 (en) * | 2004-07-13 | 2006-01-19 | UNIVERSITé LAVAL | S100 protein inhibitors for treating leukemia |
| US7659087B2 (en) | 2004-07-23 | 2010-02-09 | Aspenbio Pharma, Inc. | Methods and devices for diagnosis of appendicitis |
| US7501256B2 (en) | 2004-07-23 | 2009-03-10 | Aspenbio Pharma, Inc. | Methods and devices for diagnosis of appendicitis |
| EP1861407A1 (en) | 2005-03-24 | 2007-12-05 | Avanir Pharmaceuticals | Thienopyridinone derivatives as macrophage migration inhibitory factor inhibitors |
| GB0605689D0 (en) * | 2006-03-21 | 2006-05-03 | Novartis Ag | Organic compounds |
| US9605302B2 (en) * | 2008-09-03 | 2017-03-28 | Quantumdx Group Limited | Sensing strategies and methods for nucleic acid detection using biosensors |
| CN103562702A (zh) | 2011-05-20 | 2014-02-05 | 独立行政法人理化学研究所 | 生物材料用透明化试剂、及其利用 |
| JP2014530360A (ja) | 2011-10-07 | 2014-11-17 | バクスター・ヘルスケヤー・ソシエテ・アノニムＢａｘｔｅｒ Ｈｅａｌｔｈｃａｒｅ ＳＡ | 診断マーカーとしてのｏｘＭＩＦ |
| EP3183581A1 (en) * | 2014-08-22 | 2017-06-28 | Baxalta GmbH | Detection of cho-mif contaminations |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE230876C (fi) * | ||||
| US4322274A (en) * | 1980-08-28 | 1982-03-30 | Wilson Gregory B | Method of diagnosing cystic fibrosis patients and asymptomatic carrier of the cystic fibrosis gene |
| GB2125047B (en) | 1982-08-09 | 1986-02-19 | Ciba Geigy Ag | Yeast hybrid vectors and their use for the production of polypeptides |
| GB8318754D0 (en) * | 1983-07-11 | 1983-08-10 | Fagerhol M K F | Human proteins anti-sera test kits |
| JPS6041697A (ja) * | 1983-08-15 | 1985-03-05 | Asahi Chem Ind Co Ltd | 活性蛋白質誘導体の新規合成法 |
| EP0143081B1 (en) | 1983-11-21 | 1989-08-23 | Ciba-Geigy Ag | Synthesis of tissue plasminogen activator(tpa) by yeast |
| PT79519B (en) | 1983-11-21 | 1986-12-11 | Ciba Geigy Ag | Process for preparing protease inhibitors based on egline compounds |
| JPH0672158B2 (ja) | 1984-05-24 | 1994-09-14 | チバ−ガイギ− アクチエンゲゼルシヤフト | 精製されたヒトマクロファージ遊走阻止因子 |
| GB8915414D0 (en) * | 1989-07-05 | 1989-08-23 | Ciba Geigy | Novel cytokines |
-
1987
- 1987-09-28 EP EP87810561A patent/EP0263072B1/en not_active Expired - Lifetime
- 1987-09-28 ES ES87810561T patent/ES2052602T3/es not_active Expired - Lifetime
- 1987-09-28 DE DE3789413T patent/DE3789413T2/de not_active Expired - Fee Related
- 1987-09-30 FI FI874287A patent/FI874287A/fi not_active IP Right Cessation
- 1987-10-01 PT PT85849A patent/PT85849B/pt not_active IP Right Cessation
- 1987-10-02 AU AU79309/87A patent/AU7930987A/en not_active Abandoned
- 1987-10-02 IE IE264587A patent/IE61773B1/en not_active IP Right Cessation
- 1987-10-02 NO NO874159A patent/NO874159L/no unknown
- 1987-10-02 DK DK517787A patent/DK517787A/da not_active Application Discontinuation
-
1990
- 1990-11-21 US US07/617,485 patent/US5350687A/en not_active Expired - Fee Related
-
1995
- 1995-07-27 US US08/508,142 patent/US5702920A/en not_active Expired - Fee Related
-
1996
- 1996-12-18 JP JP8338746A patent/JPH09188698A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| PT85849A (en) | 1987-11-01 |
| DE3789413D1 (de) | 1994-04-28 |
| EP0263072A3 (en) | 1990-01-10 |
| PT85849B (pt) | 1990-07-31 |
| NO874159D0 (no) | 1987-10-02 |
| AU7930987A (en) | 1988-05-19 |
| FI874287A (fi) | 1988-04-04 |
| FI874287A0 (fi) | 1987-09-30 |
| JPH09188698A (ja) | 1997-07-22 |
| US5702920A (en) | 1997-12-30 |
| DK517787D0 (da) | 1987-10-02 |
| NO874159L (no) | 1988-04-05 |
| DE3789413T2 (de) | 1994-07-28 |
| EP0263072A2 (en) | 1988-04-06 |
| IE872645L (en) | 1988-04-03 |
| ES2052602T3 (es) | 1994-07-16 |
| US5350687A (en) | 1994-09-27 |
| IE61773B1 (en) | 1994-11-30 |
| EP0263072B1 (en) | 1994-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK517787A (da) | Lymphokinbeslaegtede peptider | |
| DK97790A (da) | Renin-inhiberende peptider | |
| DK628687D0 (da) | Vasopressinantagonister | |
| DK111489D0 (da) | Peptider | |
| DK510587D0 (da) | Vasopressinantagonister | |
| DK353788D0 (da) | Polypeptidderivater | |
| DK174388D0 (da) | Cycliske peptider | |
| DK551287A (da) | Polypeptid | |
| DK354487A (da) | Oncogen-relaterede peptider | |
| DK531986D0 (da) | Peptider | |
| DK290588A (da) | Renin-inhiberebde peptid | |
| DK253087D0 (da) | Syntetiske natriuretiske peptider | |
| DK691787A (da) | Glycosylerede glycopeptider | |
| DK345087D0 (da) | Protein | |
| MC1830A1 (fr) | Peptides | |
| DK91586D0 (da) | Peptider | |
| DK376187D0 (da) | Peptider | |
| DK91686D0 (da) | Peptider | |
| DK434986D0 (da) | Peptider | |
| DK435086D0 (da) | Peptider | |
| DK101587D0 (da) | Peptider | |
| DK596888D0 (da) | Rekombinant lymfotoksin | |
| DK528185D0 (da) | Peptider | |
| DK395685D0 (da) | Peptider | |
| DK411686D0 (da) | Peptider |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHB | Application shelved due to non-payment |